AVBP · ArriVent BioPharma, Inc.
Market Cap
$1.53B
Shares
49.31M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1868279
CUSIP
04272N102
13F (30d)
118 filings
118 filers
Visit website
Investor relations